Bajaj Healthcare peers

·Pharma & HealthChart ›

Companies like Bajaj Healthcarelatest year

Bajaj HealthcareBAJAJHCARE · FY26 · this company
Market cap₹1,059
P/E63.14×
Sales growth+18.9%
ROE3.2%
Themis MedicareTHEMISMED · FY26
Open ›
Market cap₹907
P/E820.33×
Sales growth−10.9%
ROE0.3%
Lincoln PharmaceuticalsLINCOLN · FY26
Open ›
Market cap₹1,118
P/E12.72×
Sales growth+17.1%
ROE12.3%
WanburyWANBURY · FY25
Open ›
Market cap₹571
P/E18.69×
Sales growth+24.5%
ROE70.0%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAJAJHCARE₹314.45

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,059 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
BAJAJHCARE
FY26
THEMISMED
FY26
LINCOLN
FY26
WANBURY
FY25
Peer
Average
Valuation — at last close
P/E63.14×820.33×◆ 12.72×18.69×283.91× -78%
P/B1.99×2.27×◆ 1.48×9.63×4.46× -55%
EV/EBITDA11.96×2537.06×◆ 9.02×9.58×851.89× -99%
Market Cap₹1,059 Cr₹907 Cr₹1,118 Cr₹571 Cr₹865 Cr +22%
Growth
Revenue CAGR 3Y-3.18%-1.15%◆ 9.56%5.46%4.62% -169%
Revenue CAGR 5Y—8.21%—◆ 10.29%9.25%
Net Income CAGR 3Y-28.44%-72.81%◆ 6.43%-27.91%-31.43% +10%
Revenue YoY (latest Q)18.92%-10.88%17.13%◆ 24.47%10.24% +85%
Net Income YoY (latest Q)26.87%273.08%2.21%◆ 1200.41%491.90% -95%
Profitability
EBITDA Margin◆ 17.15%0.11%14.56%12.73%9.13% +88%
Net Income Margin2.58%0.33%◆ 13.10%5.09%6.17% -58%
Return on Common Equity3.16%0.29%12.30%◆ 70.01%27.53% -89%
Return on Capital Employed13.27%-2.30%11.32%◆ 34.18%14.40% -8%
Return on Assets1.80%0.19%◆ 10.42%8.06%6.22% -71%
Credit & Quality
Total Debt/Equity0.44×0.25×◆ 0.01×2.92×1.06× -58%
Interest Coverage3.48×-0.93×◆ 82.12×1.71×27.63× -87%
Scale — latest FY
Revenue / Total Income₹611 Cr₹342 Cr₹671 Cr₹600 Cr₹538 Cr +14%
Net Income₹15.8 Cr₹1.1 Cr₹87.9 Cr₹30.5 Cr₹39.9 Cr -60%
Total Assets₹923 Cr₹598 Cr₹890 Cr₹414 Cr₹634 Cr +46%
EPS₹4.98₹0.12₹43.88₹9.32₹17.77 -72%
Book Value per Share₹158.34₹43.28₹378.25₹18.09₹146.54 +8%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.